Simplex Trading
BLRX

Simplex Trading’s BioLineRX BLRX Stock Holding History

Simplex Trading’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-105
Closed – – 8596
2025
Q3 		$0 Sell
105
-14,009
-99% -$56.2K ﹤0.01% 9074
2025
Q2 		$64K Buy
+14,114
New +$52.2K ﹤0.01% 5668
2024
Q2 		– Sell
-50
Closed -$1.34K – 8804
2024
Q1 		$2K Buy
+50
New +$2.51K ﹤0.01% 8364
2023
Q1 		– Sell
-3
Closed – – 9038
2022
Q4 		$0 Sell
3
-2
-40% -$59 ﹤0.01% 9228
2022
Q3 		$0 Sell
5
-38
-88% -$2.17K ﹤0.01% 9911
2022
Q2 		$2K Buy
43
+4
+10% +$222 ﹤0.01% 9297
2022
Q1 		$2K Sell
39
-167
-81% -$11.6K ﹤0.01% 9820
2021
Q4 		$16K Buy
+206
New +$21.5K ﹤0.01% 8595

Other funds holding BLRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's BLRX Position: Q4 2025 in Review

Simplex Trading sold out of BioLineRX (BLRX) in Q4 2025, closing a stake of 105 shares.

Simplex Trading first reported a position in BLRX in Q4 2021 and held it in 8 quarters. The position peaked at $64K in Q2 2025. 14 funds tracked by Wall St. Rank hold BLRX as of Q4 2025.

  • Simplex Trading reported no remaining BioLineRX position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 105 BioLineRX shares in Q4 2025.
  • Simplex Trading first reported a position in BioLineRX in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's BioLineRX position peaked at $64K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held BioLineRX as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.